Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES 130/0.4 in OPCAB Patients on Antiplatelets
NCT01051206Phase 4Completed
- Sponsor
- Yonsei University
- Start
- May 2009
- Primary completion
- Feb 2010
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hetastarch in hypovolemia, sponsored by Yonsei University. Started May 2009; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT01051206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01051206.